Arhiva corespondenta cercetare
Biomedica Matchmaking 2011
The Biomedica Summit <http://www.biomedica2011.com>
within institutes and enterprises to improve product innovations. It
multidisciplinary event in which science meets business, will inform
about the latest progress in research and development. It was
Aachen in 2007, held in Maastricht in 2008, was hosted in Liège in
followed by Aachen in 2010. In the upcoming years Biomedica will
on top technology centres across the entire Euregio, including
Eindhoven, Hasselt, Leuven, Liège and Maastricht.
For 2011, Biomedica Summit focus topics are:
-Biomaterials, Targeted drug delivery and Regenerative medicine
-Advanced development for (bio) pharmaceuticals and nutraceuticals
-Cardiovascular diseases and Central Nervous System diseases
-Medical devices for sustainable health care
-Imaging: From diagnosis to guided therapy
-Sensors and monitoring: From diagnosis to disease management
A multidisciplinary event in which science meets business, will
about the latest progress in research and development.
In cooperation with the organisers of Biomedica 2011, and their
Europe Network partners, Syntens and ZENIT will organise a
event, making it even easier for participants to meet their future
* BIOLOGICAL SCIENCES
* Medicine, health
Va reamintim ca urmatorul termen limita pentru proiecte de tip
este 24 martie 2011.
Eurostars este primul program european de sprijin pentru IMM-uri.
Pentru detalii, consultati, va rugam :
Pentru detalii privind conditiile de participare ale entitatilor din
Romania, contactati-l va rugam pe dl prof.Vasile Lungu :
Mult succes !
Cu multa stima,
One of the most nerve-racking things about
being tested for some medical
condition is the long wait you endure while you wait for your results to
come in. It could take anywhere from a few days to a couple of weeks to know
your results. But EU-funded researchers are changing all this. The
MICROACTIVE ('Automatic detection of disease related molecular cell
activity') project has developed a microchip that allows physicians to
diagnose a patient's condition right in their office. MICROACTIVE received
EUR 1.6 million under the EU's Sixth Framework Programme (FP6):